Integrating Omics in R&D: A new era of biomedical research

Dr. Corr is an Associate Professor and LeBert Suess Family Endowed Professor in Ovarian Cancer Research on the gynecologic oncology team at the University of Colorado Anschutz Medical Campus. He completed his undergraduate degree at Middlebury College in Middlebury, Vermont. Dr. Corr went on to attend a post-baccalaureate, pre-medical program at Bryn Mawr College in Bryn Mawr, Pennsylvania.

Dr. Corr attended medical school at Vanderbilt University Medical School in Nashville, Tennessee. Following this, he completed his residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania in Philadelphia. He completed his fellowship in gynecologic oncology at the University of Colorado.

Dr. M. Sharon Stack received her PhD degree in Biochemistry from the University of Louisville, completed post-doctoral training in biochemical pathology at Duke University Medical Center, and served for several years as a Research Assistant Professor in Pathology at Duke. In 1994, she joined the faculty in the Department of Cell & Molecular Biology at Northwestern University where she rose through the ranks to tenured Professor. While at Northwestern, Dr. Stack was also Program Leader of the Tumor Invasion, Metastasis and Angiogenesis Program of the NCI-designated RH Lurie Comprehensive Cancer Center (RHLCCC, 1999-2007) and a member of the RHLCCC Executive Committee.   She joined the University of Missouri in 2007 as the Mulligan Endowed Professor and Vice Chair for Research in the Department of Pathology and Anatomical Sciences. She is currently (since 2011) the Kleiderer-Pezold Professor of Chemistry and Biochemistry and the Ann F. Dunne and Elizabeth Riley Director of the Harper Cancer Research Institute, University of Notre Dame.

Dr. Nike Beaubier serves as Senior Vice President, Life Science Pathology at Tempus. Dr. Beaubier most recently served as Medical Director of the Diagnostic Molecular Biology Laboratory at Northwestern Memorial Hospital and Assistant Professor of Pathology at Northwestern University Feinberg School of Medicine. She earned a bachelor’s degree in molecular biology from the University of Texas, Austin, a master of science from Stanford University and her medical degree from Columbia University. She completed an Anatomic Pathology residency, followed by a Molecular Genetic Pathology Fellowship at Columbia, then a Gastrointestinal/Surgical Pathology Fellowship at Northwestern University.

Dr. Calvin Chao is the Senior Vice President of Medical Affairs at Tempus.  Previously, Dr. Chao spent thirteen years leading studies and education for the Oncotype DX Breast, Prostate, and Colon Cancer assays at Genomic Health, later acquired by Exact Sciences.  Prior to that role, he worked in various bio-pharmaceutical medical director positions at Onyx Pharmaceuticals, PDL BioPharma, TAP Pharmaceuticals, and SmithKline Beecham.

In his early career, Dr. Chao practiced as a board-certified internist and hospitalist at Kaiser Permanente in California for ten years.

He earned his MD from the University of Texas Medical Branch, completed his medical residency at Presbyterian-St. Luke’s Medical Center in Denver, Colorado, received his MBA from St. Mary’s College, California, and his BS in Chemical Engineering from University of California, Berkeley.